Literature DB >> 31199234

Canadian Urological Association guideline: Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Executive summary.

Alex Kavanagh1, Richard Baverstock2, Lysanne Campeau3, Kevin Carlson2, Ashley Cox4, Duane Hickling5, Genviève Nadeau6, Lynn Stothers1, Blayne Welk7.   

Abstract

Year:  2019        PMID： 31199234      PMCID： PMC6570601          DOI： 10.5489/cuaj.6041

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  62 in total

1.  Prognostic value of urodynamic testing in myelodysplastic patients. 1981.

Authors:  Edward J McGuire; Jeffrey R Woodside; Thomas A Borden; Robert M Weiss
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

2.  Current practice patterns in the urologic surveillance and management of patients with spinal cord injury.

Authors:  Sanjay Razdan; Line Leboeuf; David S Meinbach; David Weinstein; Angelo E Gousse
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

3.  Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients.

Authors:  K J Weld; M J Graney; R R Dmochowski
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

4.  Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury.

Authors:  Michael Nosseir; Andreas Hinkel; Jürgen Pannek
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

5.  Complications of the upper urinary tract in patients with spinal cord injury: a long-term follow-up study.

Authors:  Ja Hyeon Ku; Won Jun Choi; Kwang Yeom Lee; Tae Young Jung; Jeong Ki Lee; Won Hee Park; Hong Bang Shim
Journal:  Urol Res       Date:  2005-11-30

6.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

Authors:  Brigitte Schurch; Marianne de Sèze; Pierre Denys; Emmanuel Chartier-Kastler; Francois Haab; Karel Everaert; Pierre Plante; Brigitte Perrouin-Verbe; Catherine Kumar; Stephanie Fraczek; Mitchell F Brin
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

7.  Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.

Authors:  M Horstmann; T Schaefer; Y Aguilar; A Stenzl; K D Sievert
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

8.  Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.

Authors:  Trevor M Soergel; Mark P Cain; Rosalia Misseri; Thomas A Gardner; Michael O Koch; Richard C Rink
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Variation in urological practice amongst spinal injuries units in the UK and Eire.

Authors:  John Bycroft; Rizwan Hamid; Helen Bywater; Prasad Patki; Michael Craggs; Julian Shah
Journal:  Neurourol Urodyn       Date:  2004       Impact factor: 2.696

10.  Can higher doses of oxybutynin improve efficacy in neurogenic bladder?

Authors:  Nelson Bennett; Margie O'Leary; Ankur S Patel; Macrina Xavier; Janet R Erickson; Michael B Chancellor
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450
View more
  3 in total

1.  Expression profiles of long non-coding RNAs in neurogenic bladder of spinal cord injured rats: a transcriptomic analysis.

Authors:  Jimeng Ruan; Zhenhua Shang; Hao Yan; Bo Cui; Qi Wang; Jiangtao Wu; Chunsong Jia; Xin Cui; Jin Li; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2022-06

2.  [Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].

Authors:  Burkhard Domurath; Peter Flachenecker; Thomas Henze; Wolfgang Feneberg; Anna Brandt; Ines Kurze; Ruth Kirschner-Hermanns; Albert Kaufmann; Jörn Bremer; Manuela Vonthien; Kerstin Ratering; Christoph Schäfer; Will Nelson Vance; Paul Schmidt
Journal:  Nervenarzt       Date:  2021-01-05       Impact factor: 1.214

3.  Botulinum toxin A improves neurogenic bladder fibrosis by suppressing transforming growth factor β1 expression in rats.

Authors:  Chunsong Jia; Tianying Xing; Zhenhua Shang; Xin Cui; Qi Wang; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2021-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.